Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma

NCT01881529 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT01881529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01881529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
March 31, 2014
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse scleroderma, limited scleroderma